Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma
NCT05471843Phase 2Active, not recruiting
- Sponsor
- BeOne Medicines
- Start
- Sep 2022
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands
- Countries
- 14
01
Overview
A Phase 2 trial of sonrotoclax in mantle cell lymphoma (MCL), sponsored by BeOne Medicines. Started Sep 2022; status: active, not recruiting.
02
Drugs
sonrotoclax
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT05471843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05471843.